Skip to main content
. 2014 Sep 1;2014:920134. doi: 10.1155/2014/920134

Table 2.

Downregulated miRNAs.

miRNAs Targets Biological outcome Models References
miR-200a/miR-141 TGF-β2 COL1, COL4, FN ↓ NRK52E cells [54]

miR-29a/b/c COL1,  
COL4
COL1, COL4 ↓ NRK52E cells, MMCs, human podocytes [56]

miR-29a COL4α1/2
HDAC4
COL1, COL4 ↓
Podocytes dysfunction ↓
HK-2 cells
miR-29a transgenic mice
Podocytes
[57]

[58]

miR-29b TGF-β/SMAD3, Sp1/NF-κB ↓ db/db mice [4]

miR-451 YWHAZ p38MAPK, ECM ↓ MMCs [60]

miR-25 NOX4 NOX4 ↓ RMCs [66]

miR-93 VEGF-A VEGF, COL4α3, FN ↓ db/db mice, podocytes, renal microvascular
endothelial cells
[67]

Let-7b TGFBR1 SMAD3, ECM ↓ Diabetic mice (STZ), NRK52E cells [68]

TGFBR1: transforming growth factor beta receptor 1; VEGF-A: vascular endothelial growth factor A; Sp1: specificity protein 1; HDAC4: histone deacetylase 4; YWHAZ: tyrosine 3 monooxygenase/tryptophan 5-monooxygenase activation protein, zeta; NOX4: NADPH oxidase subunit 4; NRK52E cells: rat renal proximal tubular cell line.